Anna Gruszczak, MD, from the Department of Neurology, National Medical Institute of the Ministry of Internal Medicine, talks about the first therapeutic breakthrough for ALS patients.
On Monday, July 7, the next meeting of the AOTMiT Transparency Council.
Ministerstwo Zdrowia opublikowało zaktualizowaną listę leków, środków specjalnego przeznaczenia żywieniowego i wyrobów medycznych, których może zabraknąć w polskich aptekach. Wykaz obowiązuje od 10 lipca 2025 roku.
An interview with Prof. Karina Jahnz-Różyk, national consultant in allergology and head of the Department of Internal Medicine, Pneumonology, Allergology, Clinical Immunology and Rare Diseases at the Military Medical Institute in Warsaw.
The Health Ministry publishes an announcement from the Minister of Health regarding medicinal products not subject to financing under the procedure for emergency access to drug technologies.
On Monday, June 30, the next meeting of the Transparency Council.
- Thanks to innovative drugs, we can treat effectively with fewer visits, which means not only convenience for patients, but also real savings for the system," says Professor Robert Rejdak, head of the Department of General Ophthalmology and the Department of Ophthalmology at the Medical...
The Health Ministry has published a list of technologies with a high level of innovation.
Amyotrophic lateral sclerosis (ALS) is a severe and rapidly progressive disease with which patients live an average of 3 to 5 years. Diagnosis is a veritable odyssey, taking up to several years. Now, as never before, genetic testing is becoming crucial, as the world's first therapy has been...
The Health Ministry summarizes the July reimbursement announcement. What news for patients?
On June 12, 2025, during the General Meeting of the Association of Employers of Innovative Pharmaceutical Companies INFARMA, a new Board of Directors and Supervisory Board were elected for another 3-year term. Wiktor Janicki, President of the Management Board of AstraZeneca Pharma Poland, was...
W poniedziałek 16 czerwca kolejne posiedzenie Rady Przejrzystości.
- This is a huge success of the Polish government, which under our presidency led to a compromise among member states on the biggest reform of EU pharmaceutical law in 20 years. We supported these measures in the European forum, because they were aimed at shortening the monopoly of medicines and...
The Health Minister has announced a great success for the Polish Presidency of the EU Council. Member states have adopted a compromise on the so-called pharmaceutical package. The reform means improved access to both innovative and generic drugs.
On Monday, June 9, the next meeting of the AOTMiT Transparency Council.
Główny Inspektor Farmaceutyczny wstrzymał obrót jedną z serii szczepionki przeciw ospie wietrznej.
On Monday, June 2, the next meeting of the Transparency Council.
The draft amendment to the Reimbursement Act is an important step by the Health Ministry to improve the availability of medicines for patients and improve the operation of the pharmaceutical market in Poland. Entrepreneurs producing drugs in the country appreciate the increasing quality of...
- Restricting access to spinal cord stimulators can not only promote opioid addiction, but also exclude thousands of patients from professional and social life, says Professor Tomasz Mandat, head of the Nervous System Tumor Clinic at the National Cancer Institute.
The subcutaneous drug is administered in seconds once every two weeks. Lives change, parents return to work, children forget about the disease, they say they have regained their lives anew," says Ewelina Matuszak, president of the Sanguis Foundation - Hemophilia and Related Hemorrhagic Diathesis,...
Behind every approved drug is a decade or more of scientific rigor, clinical precision and regulatory complexity. This process, which takes a compound from the lab to pharmacy shelves, is one of the most demanding in science and industry. The path from identifying a promising molecule to...
Poland has moved up to second place in the Access GAP ranking, which assesses access to innovative therapies in the Visegrad countries, and we are now a really small distance from the leader, the Czech Republic (64 points, down 5 points). However, there is also worse news: we are very clearly...
We are no longer in doubt today. The sooner we incorporate modern treatment, the higher the clinical, economic and social benefits are for a given system," says Dr. n. ekon. Malgorzata Galazka-Sobotka, director of the Institute for Healthcare Management at Lazarski University in Warsaw.
An amendment to the reimbursement law has gone out for consultation. The main goal is to simplify procedures, remove administrative barriers and increase the availability of medicines.
Multiple sclerosis affects young people. These diagnoses come when people are actually starting their social life, family life, career. So it is extremely important that we offer therapies that fit their lifestyle," says Malina Wieczorek, president of SM Walcz o Siebie.
Following a thorough analysis of the drug safety system in Poland, the Supreme Audit Office began inspections of key institutions responsible for drug trading on May 20. Among the things to be checked will be the effectiveness of supervision of pharmaceutical establishments and measures to...
The risk of recurrence in early breast cancer is high. Despite good reimbursement decisions, there is still a group of patients with an unmet health need. - It is a huge achievement to be able to predict and secure the risk of recurrence earlier. We are counting on reimbursements that will...
Endometrial cancer is such a very loud and vocal cancer, because we get the most patients when it comes to gynecological cancers. However, it has been neglected and unnoticed for years, because there were no solutions for it in the development of medicine," says Anna Kupiecka president of the...
On Monday, April 19, the next meeting of the Transparency Council.
The Council of Ministers has adopted a draft law amending the Pharmaceutical Law, which removes the obligation for pharmaceutical companies to submit information on the planned place of delivery of medicinal products to the Integrated System for Monitoring Trade in Medicinal Products (ZSMOPL)....
© 2023 Medexpress. All Rights Reserved
